申请人:ISIS Pharmaceuticals, Inc.
公开号:US05457191A1
公开(公告)日:1995-10-10
This invention relates to compounds based on the 3-deazapurines ring system and to methods for making such compounds. The invention also generally relates to the field of "antisense" agents, agents that are capable of specific hybridization with a nucleotide sequence of an RNA. The 3-deazapurine-containing compounds of this invention can be useful for modulating the activity of RNA when incorporated into oligonucleotides. Oligonucleotides and their analogs are used for a variety of therapeutic and diagnostic purposes, such as treating diseases, regulating gene expression in experimental systems, assaying for RNA and for RNA products through the employment of antisense interactions with such RNA, diagnosing diseases, modulating the production of proteins and cleaving RNA in site specific fashions.
本发明涉及基于3-脱氧嘌呤环系统的化合物以及制备此类化合物的方法。该发明还普遍涉及“反义”试剂领域,即能够与RNA核苷酸序列特异性杂交的试剂。本发明中含有3-脱氧嘌呤的化合物可用于在寡核苷酸中调节RNA的活性。寡核苷酸及其类似物用于各种治疗和诊断目的,例如治疗疾病,在实验系统中调节基因表达,通过反义相互作用与RNA及其产物进行检测,诊断疾病,调节蛋白质的产生并以特定的方式裂解RNA。